Brief: HLS Therapeutics Announces Promotional Agreement With Pfizer For Vascepa

HLS Therapeutics

16/08/2021 11:38

Aug 16 (Reuters) - HLS Therapeutics Inc  HLS.TO :
    * HLS THERAPEUTICS ANNOUNCES PROMOTIONAL AGREEMENT WITH
PFIZER FOR
VASCEPA® IN CANADA
    * HLS THERAPEUTICS INC - HLS WILL CONTINUE TO FOCUS
PRIMARILY ON
SPECIALISTS WHILE PFIZER WILL FOCUS PRIMARILY ON PRIMARY CARE
PHYSICIANS
    * HLS THERAPEUTICS - UNDER AGREEMENT, PFIZER WILL DEPLOY A
TEAM
ACROSS CANADA TO SUPPORT EDUCATION ABOUT VASCEPA WITH PRIMARY
CARE PHYSICIAN GROUPS
    * HLS THERAPEUTICS - HLS WILL RETAIN RESPONSIBILITY OVER
VASCEPA'S
COMMERCIALIZATION AND WILL RECORD ALL REVENUE RELATED TO VASCEPA
SALES IN CANADA

Source text for Eikon:  ID:nCNWH6jgha 
Further company coverage:  HLS.TO 

 ((Reuters.Briefs@thomsonreuters.com;))